Hormonal Implants Market Research Report - Global Forecast till 2027

Global Hormonal Implants Market Research Report: Information by Hormone (Levonorgestrel and Etonogestrel), by Type (One Rod Device and Two Rod Device), by Distribution Sector (Public Sector and Private Sector), by End User (Hospitals & Clinics and Academic & Research Institutes) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6770-HCR | February 2021 | Region: Global | 105 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


The Global Hormonal Implants Market is expected to register a CAGR of ~5.0% during the forecast period of 2019 to 2025.


Hormonal implants are a highly effective and very safe form of birth control in the shape of a tiny tube that is placed under the skin of a woman’s upper arm. The size of the implant is as small as a toothpick and are made of flexible plastic, the implant contains a type of progestin hormone that stops the ovaries from releasing eggs. Additionally, higher safety from unwanted pregnancies, suitable government programs, raising awareness of contraceptives, and the growing research & development in the market is anticipated to fuel the market growth. For instance, a study stated that no pregnancy was observed in a control group of women, using the Etonogestrel-Releasing Contraceptive Implant, for a period of 5 years. On the other hand, related cases of side-effects, pricing variation, and limited availability of the product are hampering the growth of the market during the assessment period. Moreover, major companies in the market are involved in research & development, collaborations, and mergers to sustain their position in the market. For instance, in May 2016, ALLERGAN took an initiative to help the US military servicewomen access LILETTA at a Federal Supply Schedule (FSS) price of USD 55.83 to military treatment facilitiesnationwide. The initiative also includes an educational effort to raise contraception awareness among healthcare providers treating the US military servicewomen.


Segmentation


The global hormonal implants market has been segmented based on the hormone, type, distribution sector, end user, and region.


The market, based on the hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is expected to hold a major share in the market due to the wider preferability and longer durability. The market, based on, distribution sector has been further sub-segmented into a public sector and private sector. The public sector is expected to hold a major share, due to increasing adoption rates of hormonal implants in public healthcare facilities under various government regulations. The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hormonal implants market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players



  • Bayer HealthCare

  • Shanghai Dahua Pharmaceuticals Co., Ltd

  • Merck & Co., Inc.

  • Allergan

  • Others


Regional Market Summary


Global Hormonal Implants Treatment Market Share by Region, 2018 (%)
 Hormonal Implants Treatment Market


Source: World Health Organization (WHO)


The market in the Americas is expected to dominate the global hormonal implants market due to the increasing per capita healthcare expenditure and the high adoption of new technology in the region.


According to government regulations, health insurance plans must cover all methods of birth control (including the implants), in the US, is expected to drive the market growth. Furthermore, increasing expenses in research by healthcare bodies is expected to fuel the growth of the market in this region. The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, an alternative for a surgical abortion, and the involvement of key companies. For instance, a study conducted by the European Journal of Contraception & Reproductive Health Care states that the most popular long-acting reversible contraception among European women were the levonorgestrel-releasing intrauterine system and copper intrauterine device. Therefore, the market is expected to grow during the forecast period. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing awareness for contraceptives and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low per capita disposable incomes in the region.


Global Hormonal Implants Market, by Hormone



  • Levonorgestrel

  • Etonogestrel


Global Hormonal Implants Market, by Type



  • One Rod Device

  • Two Rod Device


Global Hormonal Implants Market, by Distribution Sector



  • Public Sector

  • Private Sector


Global Hormonal Implants Market, By End User



  • Hospitals & Clinics

  • Academic & Research Institutes


Global Hormonal Implants Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Research and development (R&D) companies

  • Medical device companies

  • Government research institutes

  • Academic institutes and universities

  • Market research and consulting



Frequently Asked Questions (FAQ) :


Hormonal Implants Market is dominated by the levonorgestrel segment.

The global market is expected to exhibit a strong 5% CAGR over the forecast period from 2019 to 2025.

The growing demand for contraceptives is the major driver for the hormonal implants market.

Asia Pacific is the fastest growing regional market for hormonal implants.

Leading players in the market include Bayer, Merck, and Allergan, among others.

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D and Designing

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Review

Chapter 6. Global Hormonal Implants Market, by Hormone

6.1 Overview

6.2 Levonorgestrel

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Etonogestrel

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Hormonal Implants Market, by Type

7.1 Overview

7.2 One Rod Device

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Two Rod Device

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Hormonal Implants Market, by Distribution Sector

8.1 Overview

8.2 Public Sector

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Private Sector

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Hormonal Implants Market, by End User

9.1 Overview

9.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Academic & Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Hormonal Implants Market, by Region

10.1 Overview

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Overview

11.2 Competitive Analysis

Chapter 12. Company Profile

12.1 Bayer HealthCare

12.1.1 Company Overview

12.1.2 Products Offered

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategies

12.2 Shanghai Dahua Pharmaceuticals Co., Ltd

12.2.1 Company Overview

12.2.2 Products Offered

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategies

12.3 Merck & Co., Inc.

12.3.1 Company Overview

12.3.2 Products Offered

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.3.6 Key Strategies

12.4 Allergan

12.4.1 Company Overview

12.4.2 Products Offered

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.4.6 Key Strategies

12.5 Others

Chapter 13 Appendix

13.1 References

13.2 Related Reports


LIST OF TABLES

Table 1 Global Hormonal Implants Market Synopsis, 2020-2027

Table 2 Global Hormonal Implants Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 4 Global Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 5 Global Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 6 Global Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 7 Global Hormonal Implants Market, by Region, 2020-2027(USD Million)

Table 8 Americas: Hormonal Implants Market, by Region, 2020 and 2025

Table 9 Americas: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 10 Americas: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 11 Americas: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 12 Americas: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 13 North America: Hormonal Implants Market, by Country, 2020-2027(USD Million)

Table 14 North America: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 15 North America: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 16 North America: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 17 North America: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 18 Latin America: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 19 Latin America: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 20 Latin America: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 21 Latin America: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 22 Europe: Hormonal Implants Market, by Region, 2020-2027(USD Million)

Table 23 Europe: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 24 Europe: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 25 Europe: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 26 Europe: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 27 Western Europe: Hormonal Implants Market, by Country, 2020-2027(USD Million)

Table 28 Western Europe: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 29 Western Europe: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 30 Western Europe: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 31 Western Europe: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 32 Eastern Europe: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 33 Eastern Europe: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 34 Eastern Europe: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 34 Eastern Europe: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 35 Asia-Pacific: Hormonal Implants Market, by Country, 2020-2027(USD Million)

Table 36 Asia-Pacific: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 37 Asia-Pacific: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 38 Asia-Pacific: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 39 Asia-Pacific: Hormonal Implants Market, by End User, 2020-2027(USD Million)

Table 40 Middle East & Africa: Hormonal Implants Market, by Region, 2020-2027(USD Million)

Table 41 Middle East & Africa: Hormonal Implants Market, by Hormone, 2020-2027(USD Million)

Table 42 Middle East & Africa: Hormonal Implants Market, by Type, 2020-2027(USD Million)

Table 43 Middle East & Africa: Hormonal Implants Market, by Distribution Sector, 2020-2027(USD Million)

Table 44 Middle East & Africa: Hormonal Implants Market, by End User, 2020-2027(USD Million)  

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Hormonal Implants Market

Figure 3 Market Dynamics for Global Hormonal Implants Market

Figure 4 Global Hormonal Implants Market Share, by Hormone, 2020 (%)

Figure 5 Global Hormonal Implants Market Share, by Hormone, 2020 (USD Million)

Figure 6 Global Hormonal Implants Market Share, by Type, 2020 (%)

Figure 7 Global Hormonal Implants Market Share, by Type, 2020 (USD Million)

Figure 8 Global Hormonal Implants Market Share, by Distribution Sector, 2020 (%)

Figure 9 Global Hormonal Implants Market Share, by Distribution Sector, 2020 (USD Million)

Figure 10 Global Hormonal Implants Market Share, by End User, 2020 (%)

Figure 11 Global Hormonal Implants Market Share, by End User, 2020 (USD Million)

Figure 12 Global Hormonal Implants Market Share, by Region, 2020 (%)

Figure 13 Americas: Hormonal Implants Market Share, by Region, 2020 (%)

Figure 14 North America: Hormonal Implants Market Share, by Country, 2020 (%)

Figure 15 Europe: Hormonal Implants Market Share, by Region, 2020 (%)

Figure 16 Western Europe: Hormonal Implants Market Share, by Country, 2020 (%)

Figure 17 Asia-Pacific: Hormonal Implants Market Share, by Country, 2020 (%)

Figure 18 Middle East & Africa: Hormonal Implants Market Share, by Region, 2020 (%)

Figure 19 Global Hormonal Implants Market: Company Share Analysis, 2020 (%)

Figure 20 Bayer HealthCare: Key Financials

Figure 21 Bayer HealthCare: Segmental Revenue

Figure 22 Bayer HealthCare: Geographical Revenue

Figure 23 Shanghai Dahua Pharmaceuticals Co., Ltd: Key Financials

Figure 24 Shanghai Dahua Pharmaceuticals Co., Ltd: Segmental Revenue

Figure 25 Shanghai Dahua Pharmaceuticals Co., Ltd: Geographical Revenue

Figure 26 Merck & Co., Inc.: Key Financials

Figure 27 Merck & Co., Inc.: Segmental Revenue

Figure 28 Merck & Co., Inc.: Geographical Revenue

Figure 29 Allergan: Key Financials

Figure 30 Allergan: Segmental Revenue

Figure 31 Allergan: Geographical Revenue




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.